Strong prospects for Novartis cancer drug, say analysts
April 24, 2009Research and Development, Sales and Marketing Afinitor, Novartis
The FDA has approved Novartis's Afinitor for advanced renal cell carcinoma patients who have progressed after first-line Sutent or Nexavar …
GSK freezes prices in Germany as part of PR trail
April 24, 2009Sales and Marketing GSK, Germany
GlaxoSmithKline has announced a price freeze on its drugs and vaccines in Germany for 2009. The freeze applies to drugs …
Merck Serono launches Kuvan in Europe
April 24, 2009Sales and Marketing Kuvan, Merck Serono, PKU
Kuvan, the first treatment for two rare neurological disorders, has been launched in the UK, France and Germany.Merck Serono’s drug …
Pharma welcomes UK taxation pledge
April 23, 2009ABPI
The UK government budget delivered in the gloom of the recession has provided good news for the industry, according to …
Sanofi-Aventis commits 100 million euros to Chinese expansion
April 23, 2009Research and Development Asia, China, Sanofi-Aventis
France's Sanofi-Aventis is planning a major capital investment programme in Beijing in a bid to bolster its position in the …
NICE approves Bayer’s Xarelto
April 23, 2009Research and Development Bayer, NICE, Xarelto
NICE has approved Bayer's anti-clotting treatment Xarelto, bringing it into line with Boehringer Ingelheim's rival Pradaxa. Xarelto (rivaroxaban) was assessed …
Pharma-NHS joint working
April 22, 2009Research and Development, Sales and Marketing ABPI, doctors, industry relations
An underlying principle for joint working between the NHS and the pharmaceutical industry is that it brings benefits to patients. …
GSK launches Alli in Europe
April 22, 2009Sales and Marketing Alli, Europe, GSK
GSK has launched Alli, making it the first clinically proven over-the-counter weight loss aid to be available in pharmacies across …
Deal brings single ASEAN pharma market closer
April 22, 2009Manufacturing and Production Asia
An accord signed by economic ministers of the Association of Southeast Asian Nations, aimed at bringing manufacturing standards into line, …
Little benefit to pharma from G20 initiatives
April 22, 2009Research and Development, Sales and Marketing Datamonitor, strategy
Any positive effect on the pharmaceutical industry derived from the G20 summit and European Union summit will be indirect and …
AZ shuns mega-mergers but still open to smaller deals
April 21, 2009Research and Development, Sales and Marketing AZ
AstraZeneca will not follow this year's emerging pharma trend towards mega-mergers and may instead look to smaller-scale deals, according to …
Is the UK falling behind in clinical trials?
April 21, 2009Research and Development NHS
New initiatives to bolster collaboration between the NHS, academia and industry have come amid claims that the UK is losing …
GSK buys Stiefel for $3.6bn
April 20, 2009Research and Development, Sales and Marketing GSK, MA
GSK has acquired Stiefel, the world's largest independent dermatology company, in a deal valued up to $3.6 billion. The move …
Sanofi manufacturing plant closed by Italian earthquake
April 17, 2009Manufacturing and Production Europe, Italy, Sanofi-Aventis
A manufacturing facility operated by Sanofi-Aventis in Abruzzo, Italy, remains closed following the earthquake that claimed more than 280 lives …
GSK and Pfizer to create HIV joint venture company
April 16, 2009Research and Development, Sales and Marketing GSK, HIV, Pfizer
The world's two biggest pharma companies are to join forces to develop and market new treatments for HIV.GlaxoSmithKline is a …
Amgen cuts back at US pilot plant
April 16, 2009Manufacturing and Production Amgen
The worlds largest biotech company, Amgen, is cutting 100 staff at its production facility in Bothell, Washington, as part of …
Merck acquires rights to atrial fibrillation candidate
April 16, 2009Research and Development, Sales and Marketing Merck, cv
Merck has signed an agreement with Vancouver-based Cardiome Pharma to develop its new treatment for atrial fibrillation vernakalant.Merck will pay …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
